作者: Peter H. Wiernik
DOI: 10.1007/978-3-319-64263-5_43
关键词:
摘要: The successful treatment of Hodgkin lymphoma is one the most impressive achievements modern medicine. Today more than 90% patients without fever, weight loss, or night sweats (B symptoms) are cured with optimal treatment, and 60–70% those B symptoms as well. Fortunately, do not have at presentation. These cure rates been achieved problems. Long-term complications interrupted well-being a sizeable fraction survivors, relapses—even late relapses—are still problem. Current clinical research focused on noninvasive staging disease, reducing short- long-term early diagnosis serious such cardiac disease second malignancies. For first time in decades new drugs major activity against identified their role currently being defined.